Cargando…

Anti-NT5c1A Autoantibodies as Biomarkers in Inclusion Body Myositis

Objective: Sporadic Inclusion Body Myositis (sIBM) is an inflammatory myopathy (IIM) without a specific diagnostic biomarker until autoantibodies to the cytosolic 5′-nucleotidase 1A (NT5c1A/Mup44) were reported. The objectives of our study were to determine the sensitivity and specificity of anti-NT...

Descripción completa

Detalles Bibliográficos
Autores principales:	Amlani, Adam, Choi, May Y., Tarnopolsky, Mark, Brady, Lauren, Clarke, Ann E., Garcia-De La Torre, Ignacio, Mahler, Michael, Schmeling, Heinrike, Barber, Claire E., Jung, Michelle, Fritzler, Marvin J.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2019
Materias:	Immunology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6465553/ https://www.ncbi.nlm.nih.gov/pubmed/31024569 http://dx.doi.org/10.3389/fimmu.2019.00745

Ejemplares similares

Anti–Valosin‐Containing Protein (VCP/p97) Autoantibodies in Inclusion Body Myositis and Other Inflammatory Myopathies
por: Amlani, Adam, et al.
Publicado: (2022)

The Utilization of Autoantibodies in Approaches to Precision Health
por: Fritzler, Marvin J., et al.
Publicado: (2018)

Heterogeneity of autoantibodies in 100 patients with autoimmune myositis: insights into clinical features and outcomes
por: Koenig, Martial, et al.
Publicado: (2007)

Clinical Usefulness of Autoantibodies in Idiopathic Inflammatory Myositis
por: García-De La Torre, Ignacio
Publicado: (2015)

The changing landscape of the clinical value of the PM/Scl autoantibody system
por: Mahler, Michael, et al.
Publicado: (2009)

Autoantibody Discovery, Assay Development and Adoption: Death Valley, the Sea of Survival and Beyond
por: Fritzler, Marvin J., et al.
Publicado: (2021)

Detection of autoantibodies using chemiluminescence technologies
por: Mahler, Michael, et al.
Publicado: (2016)

Autoantibodies in Systemic Autoimmune Disorders
por: Mahler, Michael, et al.
Publicado: (2014)

Update in inclusion body myositis
por: Machado, Pedro, et al.
Publicado: (2013)

Autoantibodies against a 43 KDa Muscle Protein in Inclusion Body Myositis
por: Salajegheh, Mohammad, et al.
Publicado: (2011)

Clinical evaluation of autoantibodies to a novel PM/Scl peptide antigen
por: Mahler, Michael, et al.
Publicado: (2005)

Deciphering the Autoantibody Response to the OJ Antigenic Complex
por: Fritzler, Marvin J., et al.
Publicado: (2023)

Progress in understanding the diagnostic and pathogenic role of autoantibodies associated with systemic sclerosis
por: Choi, May Y., et al.
Publicado: (2016)

Current Concepts and Future Directions for the Assessment of Autoantibodies to Cellular Antigens Referred to as Anti-Nuclear Antibodies
por: Mahler, Michael, et al.
Publicado: (2014)

Update on autoantibodies and related biomarkers in autoimmune inflammatory myopathies
por: Choi, May Y., et al.
Publicado: (2023)

Emerging technologies in autoantibody testing for rheumatic diseases
por: Olsen, Nancy J., et al.
Publicado: (2017)

Significance of Autoantibodies to Ki/SL as Biomarkers for Systemic Lupus Erythematosus and Sicca Syndrome
por: Mahler, Michael, et al.
Publicado: (2022)

HLA-DRB1 allele and autoantibody profiles in Japanese patients with inclusion body myositis
por: Oyama, Munenori, et al.
Publicado: (2020)

Myositis-specific autoantibodies are specific for myositis compared to genetic muscle disease
por: Mammen, Andrew L., et al.
Publicado: (2015)

Myositis autoantibodies and clinical phenotypes
por: Ghirardello, Anna, et al.
Publicado: (2014)

Cytosolic 5′-nucleotidase 1A autoantibody profile and clinical characteristics in inclusion body myositis
por: Lilleker, J B, et al.
Publicado: (2017)

Autoantibodies Produced at the Site of Tissue Damage Provide Evidence of Humoral Autoimmunity in Inclusion Body Myositis
por: Ray, Arundhati, et al.
Publicado: (2012)

Analysis of myositis autoantibodies in Chinese patients with cancer‐associated myositis
por: Li, Liubing, et al.
Publicado: (2020)

Development and evaluation of a standardized ELISA for the determination of autoantibodies against cN-1A (Mup44, NT5C1A) in sporadic inclusion body myositis
por: Kramp, Sabine L., et al.
Publicado: (2016)

Prevalence of Myositis-Specific Autoantibodies and Myositis-Associated Autoantibodies in COVID-19 Patients: A Pilot Study and Literature Review
por: Swartzman, Isaac, et al.
Publicado: (2022)

The reliability of immunoassays to detect autoantibodies in patients with myositis is dependent on autoantibody specificity
por: Tansley, Sarah L, et al.
Publicado: (2020)

Autoantibodies in Systemic Sclerosis: Unanswered Questions
por: Kayser, Cristiane, et al.
Publicado: (2015)

Bench to bedside review of myositis autoantibodies
por: Palterer, Boaz, et al.
Publicado: (2018)

Myositis interstitial lung disease and autoantibodies
por: Chaudhry, Shire, et al.
Publicado: (2023)

An Autoimmune Myositis-Overlap Syndrome Associated With Autoantibodies to Nuclear Pore Complexes: Description and Long-Term Follow-up of the Anti-Nup Syndrome
por: Senécal, Jean-Luc, et al.
Publicado: (2014)

Ongoing Developments in Sporadic Inclusion Body Myositis
por: Machado, Pedro M., et al.
Publicado: (2014)

The use and abuse of commercial kits used to detect autoantibodies
por: Fritzler, Marvin J, et al.
Publicado: (2003)

Toward a new autoantibody diagnostic orthodoxy: understanding the bad, good and indifferent
por: Fritzler, Marvin J.
Publicado: (2012)

Novel autoantibodies and clinical phenotypes in adult and juvenile myositis
por: Betteridge, Zoe E, et al.
Publicado: (2011)

Cytokine autoantibodies in SARS-CoV-2 prepandemic and intrapandemic samples from an SLE cohort
por: Choi, May Y, et al.
Publicado: (2022)

Genetics in inclusion body myositis
por: Rothwell, Simon, et al.
Publicado: (2017)

Detecting dysphagia in inclusion body myositis
por: Cox, F. M., et al.
Publicado: (2009)

Antiphospholipase A(2) Receptor Autoantibodies: A Comparison of Three Different Immunoassays for the Diagnosis of Idiopathic Membranous Nephropathy
por: Behnert, Astrid, et al.
Publicado: (2014)

Myositis-specific autoantibodies: detection and clinical associations
por: van Dooren, Sander H. J., et al.
Publicado: (2011)

Tropomyosin autoantibodies associated with checkpoint inhibitor myositis
por: Zaenker, Pauline, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_4jtltkmsi4kmjebo97sduqsm8f